Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $TARS | Chartloom

Compare

$AMRX vs $TARS

Amneal Pharmaceuticals Inc · Tarsus Pharmaceuticals Inc

AMRX

Amneal Pharmaceuticals Inc

TARS

Tarsus Pharmaceuticals Inc

Compare $AMRX vs $TARS

Comparing Amneal Pharmaceuticals Inc and Tarsus Pharmaceuticals Inc

AMRXAmneal Pharmaceuticals Inc

TARSTarsus Pharmaceuticals Inc

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

TARSTarsus Pharmaceuticals Inc

Market cap

$3.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.72x

Rev growth (TTM)

105.2%

YTD performance

-12.3%

52W performance

1.0%

FCF yield

1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

TARS

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

TARS

Tarsus Pharmaceuticals Inc

Market Cap

AMRX$6.25B

TARS$3.05B

Enterprise Value

AMRX$8.85B

TARS$2.91B

Price

AMRX$19.57

TARS$70.82

P/E Ratio

AMRX40.80x

TARSN/A

P/S Ratio

AMRX2.00x

TARS5.02x

EV/Sales

AMRX2.84x

TARS4.81x

EV/EBITDA

AMRX13.14x

TARS0.00x

P/B Ratio

AMRX192.54x

TARS9.87x

P/FCF Ratio

AMRXN/A

TARS54.40x

EV/FCF

AMRX-719.11x

TARS52.05x

PEG Ratio

AMRX1.98x

TARSN/A

Forward P/E (NTM)

AMRX19.08x

TARSN/A

Forward P/S (NTM)

AMRX1.89x

TARS3.72x

Revenue (TTM)

AMRX$3.12B

TARS$606M

Revenue Growth (YoY)

AMRX9.3%

TARS105.2%

Forward Rev Growth

AMRX9.0%

TARS27.2%

Gross Margin (TTM)

AMRX39.3%

TARS93.3%

Operating Margin (TTM)

AMRX14.6%

TARS0.0%

EBITDA Margin (TTM)

AMRX21.6%

TARS-7.6%

Net Margin (TTM)

AMRX5.0%

TARS-7.7%

FCF Margin (TTM)

AMRX-0.4%

TARS9.2%

Net Income (TTM)

AMRX$157M

TARS$-46M

FCF (TTM)

AMRX$-12M

TARS$56M

EPS (TTM)

AMRX$0.48

TARS-$1.07

ROE (TTM)

AMRX174.6%

TARS-1353.0%

ROA (TTM)

AMRX4.3%

TARS-812.0%

ROIC (TTM)

AMRX2.1%

TARS-1117.0%

Cash

AMRX$128M

TARS$205M

Debt

AMRX$2.73B

TARS$73M

Net Cash/Debt

AMRX$-2.60B

TARS$132M

Current Ratio (TTM)

AMRX2.20x

TARS3.20x

Quick Ratio (TTM)

AMRX1.38x

TARS3.12x

Debt/Equity (TTM)

AMRX82.62x

TARS0.21x

Debt/Assets (TTM)

AMRX0.0%

TARS0.0%

Interest Coverage (TTM)

AMRXN/A

TARSN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

TARS0.00x

Beta

AMRX1.22

TARS0.31

52W Performance

AMRX96.3%

TARS1.0%

YTD Performance

AMRX54.6%

TARS-12.3%

% from 52W High

AMRX-7.6%

TARS-22.6%

% from 52W Low

AMRX104.7%

TARS31.4%

Asset Turnover (TTM)

AMRX0.85x

TARS1.06x

FCF Yield (TTM)

AMRX-0.2%

TARS1.8%

Earnings Yield (TTM)

AMRX2.5%

TARS-1.5%

Dividend Yield (TTM)

AMRXN/A

TARSN/A

Rule of 40

AMRX8.9

TARS114.4

EV/GP/RG

AMRX1.16

TARS0.13

Ticker research

View AMRX research View TARS research

Metric	AMRX Amneal Pharmaceuticals Inc	TARS Tarsus Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.25B	$3.05B
Enterprise Value	$8.85B	$2.91B
Price	$19.57	$70.82
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	5.02x
EV/Sales	2.84x	4.81x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	9.87x
P/FCF Ratio	N/A	54.40x
EV/FCF	-719.11x	52.05x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	3.72x
Revenue & Growth
Revenue (TTM)	$3.12B	$606M
Revenue Growth (YoY)	9.3%	105.2%
Forward Rev Growth	9.0%	27.2%
Profitability
Gross Margin (TTM)	39.3%	93.3%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	-7.6%
Net Margin (TTM)	5.0%	-7.7%
FCF Margin (TTM)	-0.4%	9.2%
Net Income (TTM)	$157M	$-46M
FCF (TTM)	$-12M	$56M
EPS (TTM)	$0.48	-$1.07
ROE (TTM)	174.6%	-1353.0%
ROA (TTM)	4.3%	-812.0%
ROIC (TTM)	2.1%	-1117.0%
Financial Health
Cash	$128M	$205M
Debt	$2.73B	$73M
Net Cash/Debt	$-2.60B	$132M
Current Ratio (TTM)	2.20x	3.20x
Quick Ratio (TTM)	1.38x	3.12x
Debt/Equity (TTM)	82.62x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	0.31
52W Performance	96.3%	1.0%
YTD Performance	54.6%	-12.3%
% from 52W High	-7.6%	-22.6%
% from 52W Low	104.7%	31.4%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	1.06x
FCF Yield (TTM)	-0.2%	1.8%
Earnings Yield (TTM)	2.5%	-1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	114.4
EV/GP/RG	1.16	0.13
Ticker research	View AMRX research	View TARS research

Valuation

P/E Ratio

AMRX

40.80x

P/S Ratio

AMRX

2.00x

TARS

5.02x

EV/FCF

AMRX

-719.11x

TARS

52.05x

Growth & revenue

Revenue Growth TTM

TARS

105.2%

AMRX

9.3%

Forward Revenue Growth

TARS

27.2%

AMRX

9.0%

Profitability & performance

Gross Margin

TARS

93.3%

AMRX

39.3%

ROE

AMRX

174.6%

TARS

-1353.0%

FCF Yield %

TARS

1.8%

AMRX

-0.2%

52-Week Performance

AMRX

96.3%

TARS

1.0%

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

TARS

Tarsus Pharmaceuticals Inc

Market Cap

AMRX$6.25B

TARS$3.05B

Enterprise Value

AMRX$8.85B

TARS$2.91B

Price

AMRX$19.57

TARS$70.82

P/E Ratio

AMRX40.80x

TARSN/A

P/S Ratio

AMRX2.00x

TARS5.02x

EV/Sales

AMRX2.84x

TARS4.81x

EV/EBITDA

AMRX13.14x

TARS0.00x

P/B Ratio

AMRX192.54x

TARS9.87x

P/FCF Ratio

AMRXN/A

TARS54.40x

EV/FCF

AMRX-719.11x

TARS52.05x

PEG Ratio

AMRX1.98x

TARSN/A

Forward P/E (NTM)

AMRX19.08x

TARSN/A

Forward P/S (NTM)

AMRX1.89x

TARS3.72x

Revenue (TTM)

AMRX$3.12B

TARS$606M

Revenue Growth (YoY)

AMRX9.3%

TARS105.2%

Forward Rev Growth

AMRX9.0%

TARS27.2%

Gross Margin (TTM)

AMRX39.3%

TARS93.3%

Operating Margin (TTM)

AMRX14.6%

TARS0.0%

EBITDA Margin (TTM)

AMRX21.6%

TARS-7.6%

Net Margin (TTM)

AMRX5.0%

TARS-7.7%

FCF Margin (TTM)

AMRX-0.4%

TARS9.2%

Net Income (TTM)

AMRX$157M

TARS$-46M

FCF (TTM)

AMRX$-12M

TARS$56M

EPS (TTM)

AMRX$0.48

TARS-$1.07

ROE (TTM)

AMRX174.6%

TARS-1353.0%

ROA (TTM)

AMRX4.3%

TARS-812.0%

ROIC (TTM)

AMRX2.1%

TARS-1117.0%

Cash

AMRX$128M

TARS$205M

Debt

AMRX$2.73B

TARS$73M

Net Cash/Debt

AMRX$-2.60B

TARS$132M

Current Ratio (TTM)

AMRX2.20x

TARS3.20x

Quick Ratio (TTM)

AMRX1.38x

TARS3.12x

Debt/Equity (TTM)

AMRX82.62x

TARS0.21x

Debt/Assets (TTM)

AMRX0.0%

TARS0.0%

Interest Coverage (TTM)

AMRXN/A

TARSN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

TARS0.00x

Beta

AMRX1.22

TARS0.31

52W Performance

AMRX96.3%

TARS1.0%

YTD Performance

AMRX54.6%

TARS-12.3%

% from 52W High

AMRX-7.6%

TARS-22.6%

% from 52W Low

AMRX104.7%

TARS31.4%

Asset Turnover (TTM)

AMRX0.85x

TARS1.06x

FCF Yield (TTM)

AMRX-0.2%

TARS1.8%

Earnings Yield (TTM)

AMRX2.5%

TARS-1.5%

Dividend Yield (TTM)

AMRXN/A

TARSN/A

Rule of 40

AMRX8.9

TARS114.4

EV/GP/RG

AMRX1.16

TARS0.13

Ticker research

View AMRX research View TARS research

Metric	AMRX Amneal Pharmaceuticals Inc	TARS Tarsus Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.25B	$3.05B
Enterprise Value	$8.85B	$2.91B
Price	$19.57	$70.82
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	5.02x
EV/Sales	2.84x	4.81x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	9.87x
P/FCF Ratio	N/A	54.40x
EV/FCF	-719.11x	52.05x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	3.72x
Revenue & Growth
Revenue (TTM)	$3.12B	$606M
Revenue Growth (YoY)	9.3%	105.2%
Forward Rev Growth	9.0%	27.2%
Profitability
Gross Margin (TTM)	39.3%	93.3%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	-7.6%
Net Margin (TTM)	5.0%	-7.7%
FCF Margin (TTM)	-0.4%	9.2%
Net Income (TTM)	$157M	$-46M
FCF (TTM)	$-12M	$56M
EPS (TTM)	$0.48	-$1.07
ROE (TTM)	174.6%	-1353.0%
ROA (TTM)	4.3%	-812.0%
ROIC (TTM)	2.1%	-1117.0%
Financial Health
Cash	$128M	$205M
Debt	$2.73B	$73M
Net Cash/Debt	$-2.60B	$132M
Current Ratio (TTM)	2.20x	3.20x
Quick Ratio (TTM)	1.38x	3.12x
Debt/Equity (TTM)	82.62x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	0.31
52W Performance	96.3%	1.0%
YTD Performance	54.6%	-12.3%
% from 52W High	-7.6%	-22.6%
% from 52W Low	104.7%	31.4%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	1.06x
FCF Yield (TTM)	-0.2%	1.8%
Earnings Yield (TTM)	2.5%	-1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	114.4
EV/GP/RG	1.16	0.13
Ticker research	View AMRX research	View TARS research